Positions for Icu Medical Inc (NASDAQ:ICUI)

“Big money sentiment for Icu Medical Inc (NASDAQ:ICUI) in Q4 2018 decreased to 0.79, SEC.gov filings reveal. That’s down -0.59, from 2018Q3’s 1.38. 114 hedge funds started new and increased positions, while 144 cut down and sold their stakes in Icu Medical Inc so the sentiment has worsened. These funds own 20.11 million shares, that’s up from 14.77 million shares in 2018Q3. Funds holding Icu Medical Inc in top 10 changed to 3 from 2 for an increase of 1. In total 59 funds closed positions, 85 reduced and 79 increased. Also 35 funds bought new Icu Medical Inc stakes.

Biggest Icu Medical Inc Investors

Pura Vida Investments Llc owns 65,119 shares in Icu Medical Inc as of Q4 2018. Icu Medical Inc’s shareholder Sandhill Capital Partners Llc owns 91,082 shares as of Q4 2018. Lyon Street Capital Llc reported 11,105 shares. Penn Capital Management Co Inc revealed 51,722 shares position in Icu Medical Inc. The California-based fund Partner Fund Management L.P. holds 175,758 shares or 1.07% of their portfolio.

ICU Medical, Inc. develops, manufactures, and sells medical devices used in infusion therapy, critical care, and oncology applications worldwide.The firm is valued at $4.78 billion. It offers infusion therapy products comprising a tube running from a bottle or plastic bag containing a solution to a catheter inserted in a patient’s vein for use in hospitals and ambulatory clinics.The P/E ratio is 175.44. The company’s infusion therapy products include needlefree connector products, such as MicroClave and MicroClave Clear, Neutron, NanoClave, Clave, and SwabCap; custom infusion sets; and Tego needlefree hemodialysis connectors.

Ticker’s shares touched $233.33 during the last trading session after 0.45% change.Currently ICU Medical, Inc. is uptrending after 5.87% change in last March 10, 2018. ICUI has 196,335 shares volume. ICUI outperformed by 1.50% the S&P500.

ICU Medical, Inc. (NASDAQ:ICUI)’s earnings report is anticipated on May, 8., as reported by Faxor. Analysts expect change of 2.43 % or $0.05 from previous year?s $2.06 earnings per share compared to current’s $2.01 earnings per share. This could hit $41.20 million profit for ICUI assuming the current $2.01 earnings per share will become reality. After $1.78 earnings per share was published previous quarter, analysts now see EPS growth of 12.92 % for ICU Medical, Inc..

Huntington Bancorporation invested in 0% or 443 shs. American Group Inc stated it has 33,904 shs or 0.03% of all its holdings. Amalgamated Bancorporation reported 3,660 shs. Lyon Street Lc owns 11,105 shs. Moreover, New Mexico Educational Retirement Board has 0.04% invested in ICU Medical, Inc. (NASDAQ:ICUI). Moreover, Central Bancorporation Tru has 0.01% invested in ICU Medical, Inc. (NASDAQ:ICUI). Blackrock invested 0.02% in ICU Medical, Inc. (NASDAQ:ICUI). New York-based Alpine Woods Cap Invsts Limited Liability Company has invested 0.11% in ICU Medical, Inc. (NASDAQ:ICUI). Los Angeles Mgmt & Equity Incorporated reported 33,967 shs. Signaturefd Ltd Liability invested in 75 shs. Ftb Advsr has invested 0% in ICU Medical, Inc. (NASDAQ:ICUI). Zacks Invest accumulated 13,107 shs. Us Financial Bank De stated it has 9,117 shs. 645 are held by Assetmark Inc. Sei reported 0.01% in ICU Medical, Inc. (NASDAQ:ICUI).

ICU Medical, Inc. had 2 insider sales and 0 buys since November 15, 2018. This’s net activity of $523.49 million. SWINNEY ROBERT S also sold $363,285 worth of ICU Medical, Inc. (NASDAQ:ICUI) on Monday, January 28.

For more ICU Medical, Inc. (NASDAQ:ICUI) news announced recently go to: Seekingalpha.com, Nasdaq.com, Globenewswire.com, Seekingalpha.com or Globenewswire.com. The titles are as follows: “Pfizer sells $523M stake in ICU Medical to C.P. Pharmaceuticals – Seeking Alpha” announced on November 16, 2018, “Recent Analysis Shows Corcept Therapeutics, CDK Global, Dynavax Technologies, ICU Medical, American Vanguard, and Cabot Market Influences — Renewed Outlook, Key Drivers of Growth – Nasdaq” on February 11, 2019, “ICU Medical, Inc. to Present at the 37th J.P. Morgan Healthcare Conference – GlobeNewswire” with a publish date: December 27, 2018, “ICU Medical, Inc. (ICUI) CEO Vivek Jain on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha” and the last “ICU Medical, Inc. Announces Second Quarter 2018 Results – GlobeNewswire” with publication date: August 09, 2018.